MIRUM PHARMACEUTICALS INC (MIRM) Stock Analyst Earnings Estimates
NASDAQ:MIRM - Nasdaq - US6047491013 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 19.14M | 77.06M 302.61% | 186.374M 141.86% | 339.47M 82.14% | 428.34M 26.18% | 536.12M 25.16% | 733.35M 36.79% | 938.36M 27.96% | 1.164B 24.05% | 1.183B 1.63% | 1.406B 18.85% | 1.322B -5.97% | |
| EBITDA YoY % growth | -172.81M -66.18% | -127.98M 25.94% | -98.325M 23.17% | -60.424M 38.55% | -27.249M 54.90% | 17.949M 165.87% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -173.41M -66.26% | -131.22M 24.33% | -109.154M 16.82% | -78.07M 28.48% | -35.693M 54.28% | 69.157M 293.76% | 200.65M 190.14% | 385.56M 92.16% | 578.43M 50.02% | 489.14M -15.44% | 676.06M 38.21% | 595.49M -11.92% | |
| Operating Margin | -906.01% | -170.28% | -58.57% | -23.00% | -8.33% | 12.90% | 27.36% | 41.09% | 49.69% | 41.35% | 48.08% | 45.04% | |
| EPS YoY % growth | -6.35 -55.64% | -4.02 36.74% | -3.97 1.17% | -1.66 58.07% | -0.77 53.55% | 0.90 216.12% | 3.81 324.25% | 6.31 65.73% | 9.09 44.02% | 5.16 -43.24% | 7.25 40.51% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.29 56.80% | -0.30 44.28% | -0.24 53.90% | -0.17 42.77% | -0.11 62.44% | 0.35 216.27% | 0.72 402.13% | 1.03 700.61% | 1.40 1,402.86% |
| Revenue Q2Q % growth | 97.312M 39.91% | 96.549M 39.48% | 104.39M 34.05% | 112.86M 24.88% | 120.11M 23.43% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 977.16K 104.49% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -14.989M 54.00% | -14.83M 43.97% | -10.82M 55.35% | -5.987M 52.80% | -1.474M 90.17% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.30 47.37% | -0.46 | 0.16 | 34.54% |
| Q2 2024 Q2Q % growth | -0.52 73.20% | -0.48 | -0.04 | -7.94% |
| Q1 2024 Q2Q % growth | -0.54 32.50% | -0.49 | -0.05 | -10.52% |
| Q4 2023 Q2Q % growth | -0.66 33.13% | -0.25 | -0.41 | -166.28% |
| Q3 2023 Q2Q % growth | -0.57 44.12% | -0.64 | 0.07 | 11.08% |
| Q2 2023 Q2Q % growth | -1.94 -130.95% | -0.81 | -1.13 | -139.12% |
| Q1 2023 Q2Q % growth | -0.80 31.62% | -0.96 | 0.16 | 16.41% |
| Q4 2022 Q2Q % growth | -0.99 40.54% | -1.04 | 0.05 | 4.80% |
| Q3 2022 Q2Q % growth | -1.02 34.19% | -1.09 | 0.07 | 6.52% |
| Q2 2022 Q2Q % growth | -0.84 42.07% | -1.18 | 0.34 | 28.60% |
| Q1 2022 Q2Q % growth | -1.17 30.77% | -1.37 | 0.20 | 14.40% |
| Q4 2021 Q2Q % growth | -1.66 -16.08% | 0.35 | -2.01 | -571.72% |
| Q3 2021 Q2Q % growth | -1.55 -80.23% | -1.76 | 0.21 | 11.99% |
| Q2 2021 Q2Q % growth | -1.45 -55.91% | -0.66 | -0.79 | -119.27% |
| Q1 2021 Q2Q % growth | -1.69 -96.51% | -0.71 | -0.98 | -138.40% |
| Q4 2020 Q2Q % growth | -1.43 -81.01% | -0.73 | -0.70 | -94.91% |
| Q3 2020 Q2Q % growth | -0.86 -2.38% | -0.99 | 0.13 | 13.55% |
| Q2 2020 Q2Q % growth | -0.93 82.49% | -0.88 | -0.05 | -5.22% |
| Q1 2020 Q2Q % growth | -0.86 | -0.83 | -0.03 | -3.17% |
| Q4 2019 Q2Q % growth | -0.79 | -0.87 | 0.08 | 8.91% |
| Q3 2019 Q2Q % growth | -0.84 | -0.61 | -0.23 | -38.47% |
| Q2 2019 Q2Q % growth | -5.31 | -0.59 | -4.72 | -806.55% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 90.377M 89.37% | 83.656M | 6.721M | 8.03% |
| Q2 2024 Q2Q % growth | 77.875M 107.68% | 76.751M | 1.124M | 1.46% |
| Q1 2024 Q2Q % growth | 69.222M 119.07% | 71.575M | -2.353M | -3.29% |
| Q4 2023 Q2Q % growth | 69.554M 149.21% | 69.273M | 281K | 0.41% |
| Q3 2023 Q2Q % growth | 47.725M 154.13% | 39.371M | 8.354M | 21.22% |
| Q2 2023 Q2Q % growth | 37.497M 114.51% | 31.052M | 6.445M | 20.76% |
| Q1 2023 Q2Q % growth | 31.598M 145.14% | 29.269M | 2.329M | 7.96% |
| Q4 2022 Q2Q % growth | 27.91M 788.85% | 25.058M | 2.852M | 11.38% |
| Q3 2022 Q2Q % growth | 18.78M 275.60% | 21.224M | -2.444M | -11.52% |
| Q2 2022 Q2Q % growth | 17.48M 58.91% | 15.725M | 1.755M | 11.16% |
| Q1 2022 Q2Q % growth | 12.89M | 8.632M | 4.258M | 49.33% |
| Q4 2021 Q2Q % growth | 3.14M | 63.903M | -60.763M | -95.09% |
| Q3 2021 Q2Q % growth | 5M | 849.997K | 4.15M | 488.24% |
| Q2 2021 Q2Q % growth | 11M | 14.79M | -3.79M | -25.63% |
| Q1 2021 Q2Q % growth | 8.5M | -8.5M | -100.00% | |
| Q4 2020 Q2Q % growth | 10.2M | -10.2M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 1.91% | 0% | 7.73% |
| Revenue | 0% | 7.45% | 0% | 5.63% |